Stock KYTHERA BIOPHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Kythera Biopharmaceuticals Inc

Equities

US5015701056

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Kythera Biopharmaceuticals Inc
2015 Allergan : forecasts second-half revenue above $8 billion RE

Managers

Managers TitleAgeSince
Ambrose Bailey PSD
 President 60 15-09-30
Maria Hilado BRD
 Director/Board Member 59 15-09-30
Jere D. Fellmann PRN
 Corporate Officer/Principal 72 12-05-31

Members of the board

Members of the board TitleAgeSince
Maria Hilado BRD
 Director/Board Member 59 15-09-30
Ambrose Bailey PSD
 President 60 15-09-30
Steven Fagien BRD
 Director/Board Member - -
Jeffrey Kenkel BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,273,181 25,377,626 ( 96.59 %) 0 96.59 %

Company contact information

Kythera Biopharmaceuticals LLC

30930 Russell Ranch Road 3rd Floor

91362, Westlake

+

http://www.kytherabiopharma.com
address Kythera Biopharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Kythera Biopharmaceuticals Inc